Please Wait...

Patient Recruitment and Retention for Healthier Studies

Elizabeth Thiele

Finding patients to participate in clinical trials and keeping them engaged for the duration are two of the greatest challenges in the clinical development process. Yet, as our President and CEO John Hubbard sees it, "Every major challenge is also an opportunity to improve the clinical development process." To overcome such hurdles, we as an industry must become more efficient in conducting clinical trials while simultaneously keeping a keen focus on the patient. Opportunities abound for more effective and efficient methods to accomplish patient identification, screening, enrollment and retention.

Finding and enrolling the right patients for the right clinical trials is part of a healthy, patient-centric approach taken by Bioclinica's Patient Recruitment and Retention division. The team has a 94 percent overall success rate, with more than 200 programs successfully completed in a variety of therapeutic areas.

The approach is outlined by Elizabeth Thiele, President of our Global Clinical Research business segment, in an episode of Worldwide Business with Kathy Ireland that aired earlier this year. Elizabeth discusses the difficulty in finding eligible patients, particularly when it comes to research in areas like Alzheimer's. Tune in to the program excerpt below to hear Elizabeth explain our multi-pronged approach.

Bioclinica's Patient Recruitment and Retention Division spotlighted on Worldwide Business with Kathy Ireland!

This sponsored programming originally aired on Worldwide Business with Kathy Ireland on the Fox Business Network on April 3, 2016.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Successful clinical trials require the ability to see key details and uncover hidden insights. Bioclinica utilizes science and technology to bring clarity to clinical trials, helping companies to develop new life-improving therapies more efficiently and safely.

Come talk to #Bioclinica at #ASCO19! See why we're the world leader in #oncology imaging, helping to assess efficac… https://t.co/h0ng6StIbU
Bioclinica (13 hours ago)
Great insights for sponsors conducting #NAFLD #NASH #clinical trials. https://t.co/TG1WwRhVE8 https://t.co/US2Iobjoyd
Bioclinica (Yesterday)
Visit us at @DrugInfoAssn's DIA China to learn how Bioclinica's science & technology expertise can advance the deve… https://t.co/r4822CjVvv
Bioclinica (3 days ago)
Come talk to Bioclinica at #ASCO19! See why we're the world leader in #oncology imaging, helping to assess efficacy… https://t.co/MyomMS0Rvt
Bioclinica (6 days ago)
Great insights for sponsors conducting #NAFLD #NASH #clinicaltrials. https://t.co/TG1WwRhVE8
Bioclinica (1 week ago)
In Beijing for DIA China next week? If so, drop by Bioclinica's exhibit or catch our talk in the Randomization & Cl… https://t.co/LCNpNHabo2
Bioclinica (2 weeks ago)

Latest Blogs:

Medical Imaging of Non-Alcoholic Fatty Liver Diseases in Clinical Trials
EDC Provider Selection
Site Payments Solutions
Nonalcoholic steatohepatitis (NASH) development programs
Dr. Joby John
Transformational Trends in Investigator Site Payments
Clinical Supply Chain Success: Leveraging Technology
Blood pressure monitor
Prescription box